Wastewater SARS-CoV-2/COVID-19 Testing with ddPCR Technology

By Bio-Rad

Infected individuals shed the SARS-CoV-2 coronavirus in their feces even if they are asymptomatic, and the shed viruses are detectable in wastewater samples days before symptoms appear. Researchers can test these samples for specific viral genetic signatures without needing to perform extensive sequencing. Droplet Digital PCR (ddPCR) technology takes wastewater testing to the next level with the sensitivity and precision needed to reliably detect the presence of specific variants in wastewater samples, even at extremely low concentrations. Compared to common alternative approaches, it is less variable and has simpler data analysis. Download the white paper to learn more about ddPCR technology's benefits and applications for wastewater surveillance.

Download the White Paper

About Bio-Rad

Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers include university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality.